CHE

Chemed Corporation Healthcare - Medical Care Facilities Investor Relations →

NO
5.7% ABOVE
↑ Moving away Was 1.9% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $518.63
14-Week RSI 49
Rel. Volume (14w) This week's trading vs. the 14-week average 1.0x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.96

Chemed Corporation (CHE) closed at $548.20 as of 2026-11-13, trading 5.7% above its 200-week moving average of $518.63. The stock moved further from the line this week, up from 1.9% last week. The 14-week RSI sits at 49, indicating neutral momentum.

Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.96 ratio) is neutral — neither side is clearly dominating.

Over the past 2745 weeks of data, CHE has crossed below its 200-week moving average 38 times. On average, these episodes lasted 14 weeks. Historically, investors who bought CHE at the start of these episodes saw an average one-year return of +15.1%.

With a market cap of $7.1 billion, CHE is a mid-cap stock. The company generates a free cash flow yield of 3.7%. Return on equity stands at 29.1%, indicating strong profitability. The stock trades at 8.2x book value.

The company has been aggressively buying back shares, reducing its share count by 7.8% over the past three years. CHE passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.

Over the past 33.9 years, a hypothetical investment of $100 in CHE would have grown to $7160, compared to $3136 for the S&P 500. That represents an annualized return of 13.4% vs 10.7% for the index — confirming CHE as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 8.8% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CHE vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CHE Crosses Below the Line?

Across 17 historical episodes, buying CHE when it crossed below its 200-week moving average produced an average return of +14.8% after 12 months (median +8.0%), compared to +6.6% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +31.3% vs +9.3% for the index.

Each line shows $100 invested at the moment CHE crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CHE would reach each dislocation threshold.

Current Bean Score +1.09σ
Current FCF Yield 4.11%
Baseline Yield 4.44%
Historical σ 0.81pp

Dislocation Price Levels

Prices where CHE's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$465.02Unusually cheap — analysis point
Value+1σ$557.69Cheap vs. own history
Fair Value+0σ$696.48Historical mean behavior
Expensive-1σ$927.24Expensive vs. own history
Deep Expensive-2σ$1386.66Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-27$6.44$6.75+4.9%
2026-07-28$5.60$6.06+8.2%
2026-04-23$5.30$5.65+6.5%
2026-02-25$7.03$6.42-8.7%
Data depth: 2 quarterly baselines, 32 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CHE's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation +0.90σ Dividend yield vs own 10-yr norm
Drawdown Score +0.57σ Distance from line vs own history
Sector-Relative +0.54σ Vs sector median this week
Buyback Acceleration -3.1pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History -0.7pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (-1.0pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

CHE has crossed below its 200-week MA 38 times with an average 1-year return of +15.1% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 1974Jul 19756571.7%-51.1%+24922.6%
Jul 1975Jan 19762327.6%+24.7%+30064.3%
May 1976Jun 197633.9%+37.2%+28130.6%
Oct 1976Nov 197632.2%+23.7%+27424.9%
Mar 1982Mar 198210.2%+93.1%+15191.6%
Jul 1984Jul 198410.4%+13.4%+10094.4%
Sep 1984Jan 1985187.7%+9.4%+10238.0%
Apr 1985Jun 198583.4%+38.1%+9774.4%
Aug 1985Aug 198510.1%+13.6%+9270.2%
Sep 1985Nov 198588.6%+3.4%+9350.6%
Dec 1985Dec 198510.3%+21.8%+9113.3%
Aug 1986Aug 198610.3%+36.4%+8434.8%
Sep 1986Sep 198627.1%+35.7%+8743.3%
Oct 1986Oct 198610.5%+17.8%+8434.8%
Oct 1987Dec 19871016.8%+9.8%+8924.5%
May 1988Sep 19882011.0%+6.3%+8147.2%
Oct 1988Jan 1989139.6%+12.9%+8116.4%
Jan 1989Feb 198922.1%+3.7%+8061.5%
Mar 1989Mar 198910.8%+0.2%+7979.8%
Jan 1990Feb 199012.3%-39.5%+7770.2%
Mar 1990Nov 19918841.2%-21.6%+7962.9%
Jul 1998Nov 19981921.2%+7.1%+4355.9%
Jan 1999May 19991618.7%+4.6%+4441.4%
May 1999Jun 199920.7%+1.9%+4240.5%
Jul 1999Aug 199910.1%-8.3%+4189.8%
Aug 1999May 20004120.7%+0.1%+4254.6%
Jun 2000Sep 2000127.8%+17.0%+4444.9%
Jul 2001Aug 2001210.4%+22.6%+4600.6%
Aug 2001Nov 20011312.1%+14.2%+4258.7%
Jul 2002Jul 200212.3%+27.0%+4170.0%
Sep 2002Sep 200210.5%+24.4%+4056.4%
Oct 2002Oct 200211.5%+25.6%+4097.3%
Sep 2006Oct 200610.4%+93.6%+1815.7%
Mar 2008Oct 20098330.3%-13.0%+1311.9%
Oct 2009Nov 200952.2%+31.3%+1240.3%
Sep 2022Oct 202242.8%+19.4%+27.5%
Jun 2025Jul 20265629.0%+4.0%+16.6%
Sep 2026Oct 202673.5%N/A+6.2%
Average14—+15.1%—

Frequently Asked Questions

Is CHE below its 200-week moving average?

No. Chemed Corporation (CHE) is currently 5.7% above its 200-week moving average of $518.63. It would need to fall to $518.63 to cross below the line.

What is CHE's 200-week moving average price?

Chemed Corporation's 200-week moving average is $518.63 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CHE drops below its 200-week moving average?

CHE has crossed below its 200-week moving average 38 times in our data. On average, buying at that moment produced a one-year return of +15.1%. These dips have historically been decent entry points. These episodes lasted 14 weeks on average.

Is CHE a good value right now?

Here's what our data says about CHE as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 49. Free cash flow yield is 3.7%. Return on equity is 29.1%. Price-to-book is 8.2x. This is not a buy or sell recommendation — always do your own research.

How does CHE compare to the S&P 500?

Over the past 33.9 years, $100 invested in CHE would have grown to $7160, compared to $3136 for the S&P 500. That's 13.4% annualized vs 10.7% for the index. CHE has outperformed the broader market over this period.

Does CHE pay a dividend?

Yes. Chemed Corporation currently pays a dividend yield of 51.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13